Gilde Healthcare logo

Gilde Healthcare

Europe, Utrecht, The Netherlands, Utrecht

Description

Gilde Healthcare is a specialized healthcare investor based in Utrecht, The Netherlands, with a strong focus on both later-stage venture capital and lower mid-market buyouts. The firm manages over €2 billion (approximately $2.1 billion) across its distinct fund strategies, positioning itself as a significant player in the European and North American healthcare investment landscape. Their investment approach is characterized by deep sector expertise and a commitment to fostering growth in their portfolio companies.

Their Venture & Growth strategy targets innovative companies developing novel therapeutics, diagnostics, medical devices, and digital health solutions. Within this arm, Gilde Healthcare typically participates in Series A and B funding rounds. Initial investments for venture deals generally range from €5 million to €15 million, with the capacity to invest up to €30 million over the lifecycle of a portfolio company. This approach supports high-growth businesses poised for significant market disruption, often requiring substantial capital to scale their innovations.

Complementing their venture activities, Gilde Healthcare's Private Equity strategy focuses on profitable, lower mid-market healthcare companies. This includes investments in healthcare providers, suppliers of medical products and services, and contract research organizations. For these private equity transactions, the firm typically deploys equity investments ranging from €10 million to €50 million per company. This dual-pronged strategy allows Gilde Healthcare to address a broad spectrum of opportunities across the healthcare value chain, from early innovation to established businesses seeking growth or consolidation.

The firm's robust capital base and clear investment focus enable it to provide substantial support to its portfolio companies. Gilde Healthcare's commitment to building sustainable value, combined with its strategic presence in key healthcare markets, underscores its influential role in the evolving global healthcare sector.

Investor Profile

Gilde Healthcare has backed more than 119 startups, with 12 new investments in the last 12 months alone. The firm has led 45 rounds, about 38% of its total and boasts 37 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in United States, The Netherlands, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 3 rounds in the past year.
  • Typical check size: $5.4M – $53.6M.

Stage Focus

  • Series B (22%)
  • Series C (18%)
  • Series A (17%)
  • Series D (13%)
  • Series Unknown (13%)
  • Private Equity (8%)
  • Series E (5%)
  • Series F (2%)
  • Seed (1%)
  • Series G (1%)

Country Focus

  • United States (34%)
  • The Netherlands (18%)
  • United Kingdom (9%)
  • Denmark (8%)
  • Germany (8%)
  • Switzerland (6%)
  • Ireland (5%)
  • Belgium (4%)
  • Spain (4%)
  • France (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Health Diagnostics
  • Life Science
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gilde Healthcare frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 9
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 15
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 17
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 13
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 6
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 12
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 7
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 11
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 9

Which angels does Gilde Healthcare often collaborate with?

GP
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
JD
Europe, Noord-Brabant, The Netherlands, Eindhoven
Shared Deals: 1

What are some of recent deals done by Gilde Healthcare?

Splice Bio

Barcelona, Catalonia, Spain

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

BiotechnologyLife ScienceMedicalPharmaceutical
Series BJun 11, 2025
Amount Raised: $135,000,000
Spyglass Pharma

Aliso Viejo, California, United States

Spyglass Pharma provides medicine for ophthalmic diseases.

DeliveryMedicalPharmaceutical
Series DJun 2, 2025
Amount Raised: $75,000,000
MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareMedicalMedical Device
Series FMar 12, 2025
Amount Raised: $65,000,000
Shoulder Innovations

Holland, Michigan, United States

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

BiotechnologyHealth CareMedical Device
Series EMar 10, 2025
Amount Raised: $40,000,000
GT Medical Technologies

Tempe, Arizona, United States

GT Medical Technologies is a medical device company that offers innovative medical solutions for brain tumor patients.

Health CareMedicalMedical DeviceTherapeutics
Series DJan 16, 2025
Amount Raised: $37,000,000
Alleviant Medical

Austin, Texas, United States

Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.

BiotechnologyClinical TrialsHealth CareMedical Device
Series UnknownJan 14, 2025
Amount Raised: $90,000,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
Noema Pharma

Basel, Basel-Stadt, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

BiotechnologyMedicalPharmaceutical
Series BDec 11, 2024
Amount Raised: $30,567,953
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
SynOx Therapeutics

Dublin, Dublin, Ireland

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

BiotechnologyMedicalTherapeutics
Series BOct 30, 2024
Amount Raised: $92,000,000